Accelus

Accelus is a promising startup in the health care industry, focusing on accelerating minimally invasive spine surgery. The company's slogan "Accelerating Minimally Invasive Spine Surgery" reflects its commitment to innovation and efficiency in the field. Accelus follows a procedure-centric approach, prioritizing the design of implants and instruments to elevate the surgical experience and enhance patient outcomes. Their cutting-edge Adaptive Geometry™ technologies cater to various spine surgeries, including transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF), endoscopic-assisted percutaneous, and lateral spine surgeries. Established in 2021 and headquartered in the United States, Accelus has gained notable attention in the industry. The company recently secured a significant $20.00M debt financing investment on 18 January 2024, with Symbiotic Capital participating as the investor. This investment underscores the confidence of the investor in Accelus' vision and technological advancements. With their relentless pursuit of excellence, Accelus is poised for further growth and impact in the minimally invasive spine surgery space.